News bites: GOP's plans for Medicare, new FDA pathways and more

Kaiser Health News examines what the traditional Medicare program would look like under Republican plans to keep it as an option alongside private insurance subsidies for seniors.

The FDA is considering a new approval pathway for drugs to treat life-threatening conditions for which there are few approved therapies, MedPage Today reports.

The Medicare and Medicaid statutes are incomprehensible, and judges aren't amused, The Wall Street Journal reports.

Antibiotic-resistant bacteria sickened 167 people in the United States last year, says a new white paper from the Center for Science in the Public Interest.